As the 118th Congress kicks into gear, biopharma industry observers speculate that 2023 may be a challenging year.
Tag Archive for: 118th Congress
A frenzied lame-duck session and a showdown over federal spending are in prospect as Washington prepares for the 118th Congress. What will this mean for healthcare policy?
